INCREASING PRODUCTION OF PROTEINS IN GRAM-POSITIVE MICROORGANISMS

Abstract: The present invention relates to secretion in Gram-positive microorganisms. The present invention provides the nucleic acid and amino acid sequences for the Bacillus subtilis secretion factors SecDF. The present invention also provides improved methods for the secretion of heterologous or homologous proteins in gram-positive microorganisms.

Description: INCREASING PRODUCTION OF PROTEINS IN GRAM-POSITIVE MICROORGANISMS FIELD OF THE INVENTION The present invention generally relates to expression of proteins in gram-positive microorganisms and specifically to the gram positive microorganism secretion factor SecDF. The present invention provides expression vectors, methods and systems for the production of proteins in gram-positive microorganisms. BACKGROUND OF THE INVENTION Gram-positive microorganisms, such as members of the group Bacillus, have been used for large-scale industrial fermentation due, in part, to their ability to secrete their fermentation products into the culture media. In gram-positive bacteria, secreted proteins are exported across a cell membrane and a cell wall, and then are subsequently released into the external media usually obtaining their native conformation. Secretion factors from Gram-positive microorganisms which have been identified and reported in the literature include SecA (Sadaie Y., Takamatsu h., Nakamura k., Yan ane k.; Gene 98:101-105, 1991)., SecY (Suh J.-W., Boylan S.A., Thomas S.M., Dolan K.M., Oliver D.B., Price C.W.; Mol. Microbiol. 4:305-314, 1990)., SecE (Jeong S., Yoshikawa H., Takahashi H.; Mol. Microbiol. 10:133-142, 1993), FtsY an FfH (PCT/NL 96/00278), and PrsA (WO 94/19471). By contrast, in the gram-negative microorganism, E.coli, protein is transported to the periplasm rather than across the cell membrane and cell wall and into the culture media. E.coli has at least two types of components of the secretory mechanism, soluble cytoplasmic proteins and membrane associated proteins. Reported E.coli secretion factors include the soluble cytoplasmic proteins, SecB and heat shock proteins; the peripheral membrane- associated protein SecA; and the integral membrane proteins SecY, SecE, SecD and SecF. In spite of advances in understanding portions of the protein secretion machinery in procaryotic cells, the complete mechanism of protein secretion, especially for gram-positive microorganisms, such as Bacillus, has yet to be fully elucidated. SUMMARY OF THE INVENTION The capacity of the secretion machinery of a Gram-positive microorganism may become a limiting factor or bottleneck to protein secretion and the production of proteins in secreted form, in particular when the proteins are recombinantly introduced and overexpressed by the host cell. The present invention provides a means for alleviating that bottle neck. The present invention is based, in part, upon the identification of the Bacillus secretion factor SecDF and upon the unexpected finding that, in contrast to SecD and SecF of E.coli, Bacillus SecDF is encoded by one nucleic acid sequence. The present invention is also based upon the unexpected finding that SecDF has sequence as well as structural similarity to secondary solute transporters The present invention is also based, in part, upon the finding that SecDF mutants of B. subtilis have a cold-sensitive phenotype for growth and further that the rate of processing of exo-enzymes, amylase and neutral protease, is decreased in SecDF mutants of B subtilis The present invention is also based, in part, upon the finding that B subtilis SecDF, which has twelve putative transmembrane domains is required for efficient translocation of secretory pre-proteins under conditions of hyper-secretion The present invention provides isolated nucleic acid and ammo acid sequences for B subtilis SecD, SecF and SecDF The amino acid sequence and nucleic acid sequence for B subtilis SecDF is shown in Figures 1A-1 E The present invention also provides improved methods for secreting proteins from gram-positive microorganisms Accordingly the present invention provides an improved method for secreting desired proteins in a gram-positive microorganism comprising the steps of obtaining a gram positive microorganism comprising nucleic acid encoding at least one Bacillus secretion factor selected from the group consisting of SecD, SecF and SecDF wherein said secretion factor is under the control of expression signals capable of expressing said secretion factor in a gram-positive microorganism said microorganism further comprising nucleic acid encoding said protein, and culturing said microorganism under conditions suitable for expression of said secretion factor and secretion of said protein In one embodiment of the present invention, the protein is homologous or naturally occurring in the gram-positive microorganism In another embodiment of the present invention, the protein is heterologous to the gram-positive microorganism The present invention provides expression vectors and host cells comprising at least one nucleic acid encoding a gram-positive secretion factor selected from the group consisting of SecD, SecF and SecDF In one embodiment of the present invention, the host cell is genetically engineered to produce a desired protein, such as an enzyme, growth factor or hormone In yet another embodiment of the present invention, the enzyme is selected from the group consisting of proteases, carbohydrases including amylases, cellulases, xylanases, reductases and lipases, isomerases such as racemases, epimerases, tautomerases, or mutases, transferases, kinases and phophatases acylases, amidases, esterases, oxidases. In a further embodiment the expression of the secretion factor SecD, SecF and/or SecDF is coordinated with the expression of other components of the secretion machinery Preferably other components of the secretion achinary, i e , translocase, SecA, SecY, SecE and/or other secretion factors known to those of skill in the art are modulated in expression at an optimal ratio to SecD, SecF or SecDF For example, it may be desired to overexpress multiple secretion factors in addition to SecDF for optimum enhancement of the secretion machinary The present invention also provides a method of identifying homologous non Bacillus subtilis secretion factors that comprises hybridizing part or all of secDF nucleic acid shown in Figures 1A-1E with nucleic acid derived from gram-positive microorganisms. In one embodiment, the nucleic acid is of genomic origin. In another embodiment, the nucleic acid is a cDNA. The present invention encompasses novel gram-positive secretion factors identified by this method. BRIEF DESCRIPTION OF THE DRAWINGS Figures 1A-1E shows the nucleic acid sequence for secDF (SEQ ID NO:1) and the deduced amino acid sequence of SecDF (SEQ ID NO:2). Figure 2 shows the decreased rate of processing of pre-AmyQ in SecDF mutants of B.subtilis. Mutant strain (MIF1) and wildtype B. subtilis (168) harboring a plasmid encoding AmyQ (ρKTH10; Takkinen K., Pettersson R.F., Kalkkinen N., Palva I., Soderlund H., Kaariainen L J. Biol. Chem. 258:1007-1013(1983).) were tested for precursor and mature amylase using western blot analysis: lane 1 and 2: proteins secreted into the medium lane 3 and 4: total cell proteins analyzed. Figures 3A-3B shows the expression of secDF in B. subtilis grown in TY medium (3A) and minimal media (3B) as measured by β-gal. Figure 4A-4B show the levels of AmyQ (Bacillus amyloliquefaciens α-amylase) accumulated in B.subtilis MIF1 relative to wildtype as a measurement of the total amount of AmyQ (Figure 4A) and as a percentage of pre-AmyQ (Figure 4B). Data are derived from the gel analysis of figure 2. Figure 5A and 5B show a pulse chase experiment of amylase made in wild type B. subtilis and B. subtilis MIF1 (insertional inactivation of SecDF). Figure 5A is a 10% SDS gel with lane 2, 3 and 4 illustrating the levels of protein seen at 1' , 2' and 10' in wild type B.subtilis and lanes 5, 6 and 7 illustrating the levels of protein seen at 1', 2' and 10' in B. subtilis MIF1. After pulse chase the cells were lysed and the proteins were selectively precipitated with anti-amylase antibodies. Figure 5B shows the percentage of AmyQ precursor at chase times 1', 2', 5' and 10' of wild type β. subtilis and B. subtilis MIF1. Figures 6A-6C. Figure 6A illustrates a chromosomal organization of the B.subtilis secDF locus (adapted from the Subtilist database; http://www.pasteur.fr.Bio/SubtiList .html): Figure 6B illustrates the chromosomal organization of the E.coli secD locus (adapted from Pogliano, et al., 1994, J. Bacteriol. 176:804-814 and Reuter et al., 1991 , J. Bacteriol. RECTIFIED SHEET (RULE 91) ISA/EP 173:2256-2264). Figure 6C is a comparison of the deduced amino acid sequences of SecDF of B.subtilis and SecD (SEQ ID NO:3) and SecF (SEQ ID NO:4) of E.coli. Identical amino acids (*), or conservative replacements (.) are marked. The conserved regions D1-D6 and F1-F4, which are present in all known SecD and SecF proteins/domains are marked with s black, or open bars. Putative membrane-spanning domains (l-XII) are indicated in gray shading. The membrane-spanning domains of E.coli SecD and SecF were adapted from Pogliano et al., 1994, J. Bacteriol. 176:804-814 and GenBank sequence ID number 134401 , respectively. The membrane spanning domains in SecDF of B.subtilis were predicted using algorithms described by Sipos and von Heijne (Sipos et al., 1993, Eur. J. Biochem 213:1333- o 1340). The point of truncation of the SecDF protein in B.subtilis is indicated with an arrow. Figure 7 illustrates the growth at 5°C as a function of time as measured at OD600 for the strains B.subtilis 168 pGS1 (neutral protease expression plasmid), B.subtilis 168 pKTH10 (amylase expression plasmid), B.subtilis MIF1 pKTH10 and B.subtilis MIF1 pGS1. 5 Figure 8 illustrates the genomic map of the nucleic acid encoding secDF and surrounding nucleic acid. Figures 9A-9B illustrates the restriction map of plasmids MID2 (MID2 and MID refer to 0 the same plasmid) (9A) and MIF1 (MIF and MIF1 refer to the same plasmid) (9B) containing internal secDF fragments which have been interrupted. Figure 10: Demonstration that SecDF is a single protein in B. subtilis. A fusion was made between the ORF encoding B. subtilis SecDF and a c-myc polypeptide. This fusion 5 protein was detected in a Western blot using antibodies directed to c-myc. It can be seen that a 97 kDa protein is detected corresponding to the expected size for a SecDF/myc fusion. lane 1: overnight culture of E. coli (in TY) with plasmid pX-DFmyc lane 2: e overnight culture B. subtilis 168 DF-myc (in TY) without xylose induction lane 3: same as 2 grown with xylose induction 0 Size markers have been given (in kDa). pX-DFmyc was obtained from Dr. W. Schumann: it is a vector that will replicate in E.coli and integrate in Bacillus. The secDF gene has been cloned with a myc-tag at the C-terminus of SecDF. The secDF gene is under the control of the inducible xylose promoter. 5 Figure 11 : Impaired extracellular accumulation of AmyQ. Cells overexpressing amylase were grown under two different conditions: at 37 °C during 1 hour and at 15 °C during 16 hours. The amount of secreted amylase was determined with Western blot analysis. lane 1 : β. subtilis 168 (pKTH10); medium after 1 hour growth at 37 °C RECTIFIED SHEET (RULE 91) lane 2 :B. subtilis MIF1 (pKTHIO); medium after 1 hour growth at 37 °C. lane 3: B. subtilis 168 (pKTHIO); medium after 16 hours growth at 15 °C lane 4: B. subtilis MIF1 (pKTHIO); medium after 16 hours growth at 15 °C The bands have been scanned and analyzed: after 1 hour at 37 C strain MIF1 secretes 72 % compared to wildtype; after 16 hours at 15 C MIF1 secretes only 20 % compared to wild type level. Figure 12; Impaired secretion of neutral protease. Cells overexpressing neutral protease (from plasmid GS1) were grown under two different conditions: at 37 °C during 1 hour and at 15 °C during 16 hours. The amount of secreted neutral protease was determined with Western blot analysis. lane 1 : B. subtilis 168 (pGS1); medium after 1 hour growth at 37 °C lane 2 :B. subtilis MIF1 (pGS1); medium after 1 hour growth at 37 °C. lane 3: B. subtilis 168 (pGS1); medium after 16 hours growth at 15 °C lane 4: B. subtilis MIF1 (pGS1); medium after 16 hours growth at 15 °C The amounts of neutral protease have been quantified: after 1 hour at 37 °C: MIF1 secretes 47% NprE compared to wildtype; after 16 hours at 15 °C: MIF1 secretes 43% NprE compared to wildtype. Figure 13 shows the amino acid alignment of E.coli SecD (SEQ ID NO:3) with Bacillus subtilis SecDF (SEQ ID NO:2). Figure 14 shows the amino acid alignment of E.coli SecF (SEQ ID NO:4) with Bacillus subtilis SecDF (SEQ ID NO:2). Figure 15 shows the putative membrane-spanning domains numbered I— XI II . The positions of the patterns of conserved residues (D1-D6 and F1-F4) are indicated in bold. The carboxyl-terminus of the truncated SecDF protein of B.subtilis MIF is marked with and arrow. N is the amino-terminus and C is the carboxyl-terminus. Figure 16A-16C. Figure 16A shows a schematic presentation of the secDF locus of B.subtilis MID. By a single-crossover event (Campbell-type integration), the secDF promoter region was replaced with the Pspac promoter of the integrated plasmid pMutin2, which can be repressed by the product of the lacl gene. Simultaneously, the spoVG-lacZ reporter gene of pMutin2 was placed under the transcriptional control of the secDF promoter region. The chromosomal fragment from the secDF regions which was amplified by PCR and cloned into pMutin2, is indicated with black bars. Only the restriction sites relevant for the construction are shown. PsecDF promoter region of the secDF gene; ori pBR322, replication functions of pBR322; secDF', 3' truncated secDF gene; T^, transcriptional terminators on pMutin2; SL, putative rho-independent terminator of secDF transcription. Figure 16B is a schematic RECTIFIED SHEET (RULE 91) presentation of the secDF locus of B.subtilis MIF. The secDF gene was disrupted by the integrated plasmid pMutin2. 'secDF, 5' truncated secDF gene. Figure 16C shows the growth of secDF mutants in Ty medium at 15°C. Overnight cultures of strains grown in TY medium at 37°C were diluted 100-fold in fresh TY medium and incubated at 15 °C. Growth of B.subtilis 168 is shaded squares; 168 (pKTHIO) open squares; MID closed triangle; MIDpKt O open triangle; MIF closed circle; MIF (pKt1110) open circles in the absence of IPTG, was determined by optical density readings at 600nm. Growth of B.subtilis MID and MID (pKTHIO) open triangles was determined in medium supplemented with IPTG. Figures 17A-17D shows the identification of the SecDF protein in B.subtilis. To identify the SecDF protein, cells of B.subtilis XDF-Myc, which contain the secDFmyc gene under control of a xylose-inducible promoter, were grown in the absence or presence of xylose and protoplasted. In parallel, protoplasts were incubated for 30 min without further additions, in the presence of trypsin (1mg/ml), or in the presence of tyrpsin and Triton X-100 (1%). Samples were used for SDS-PAGE and Western blotting. Figure 17A illustrates that SecDF-Myc was visualized with specific antibodies against the c-Myc epitope. Figure 17B shows SipS (extracellular control) and Figure 17C shows GroEL (cytoplasmic control) which were visualized with specific antibodies. Figure 17D shows limited proteolysis of SecDF-Myc with trypsin (1mg/ml) that was per ormed by incubation for various periods of time. Intact SecDF-Myc (82kDa), trypsin resistant fragments of SecDF-Myc (54kDa and 23 kDa), SipS and GroEL are indicated. DETAILED DESCRIPTION Definitions As used herein, the genus Bacillus includes all members known to those of skill in the art, including but not limited to B. subtilis, B. licheniformis, B. lentus, B. brew ' s, B. stearOthermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B. circulans, B. lautus and B. thuringiensis. The present invention encompasses novel SecD, SecF and SecDF secretion factors from any gram positive organism. In a preferred embodiment, the gram-positive organism is Bacillus. In another preferred embodiment, the gram-positive organism is from B. subtilis. As used herein, the phrase, "B.subtilis SecDF secretion factor" refers to the amino acid sequence shown in Figures 1A-1E as well as the amino acid sequence encoded by the nucleic acid disclosed in Kunst et al., 1997, Nature 390:249-256 (GenBank accession number ID g2635229) and GenBank accession number AF024506 and the present invention encompasses the SecDF amino acid sequence encoded by secDF nucleic acid disclosed in ' Figures 1A-1 E, GenBank accession number ID g2635229 and accession number AF024506. The present invention encompasses amino acid variants of Bacillus subtilis that are able to RECTIFIED SHEET (RULE 91) modulate secretion alone or in combination with other secretions factors in gram-positive microorganisms As used herein, "nucleic acid" refers to a nucleotide or polynucleotide sequence, and fragments or portions thereof, and to DNA or RNA of genomic or synthetic origin which may 5 be double-stranded or single-stranded, whether representing the sense or antisense strand As used herein "ammo acid" refers to peptide or protein sequences or portions thereof As used herein, lower case "secDF' is used to designate a nucleic acid sequence, whereas upper case "SecDF" is used to designate an ammo acid sequence A "B subtilis polynucleotide homolog" or "polynucleotide homolog" as used herein refers to a o polynucleotide that has at least 80%, at least 90% and at least 95% identity to Figures 1A-1 E or which is capable of hybridizing to part or all of the nucleic acid of Figures 1 A-1 E under conditions of high stringency and which encodes an ammo acid sequence that is able to modulate secretion of the gram-positive microorganism from which it is derived Modulate as used herein refers to the ability of a secretion factor to alter the secretion machinery such s that secretion of proteins is altered The terms "isolated" or "purified" as used herein refer to a nucleic acid or ammo acid that is removed from at least one component with which it is naturally associated As used herein, the term "heterologous protein refers to a protein or polypeptide that does not naturally occur in a gram-positive host cell Examples of heterologous proteins o include enzymes such as hydrolases including proteases cellulases, amylases, other carbohydrases, and lipases, isomerases such as racemases epimerases, tautomerases, or mutases, transferases, kmases and phophatases The heterologous gene may encode therapeutically significant proteins or peptides such as growth factors, cytokines, ligands, receptors and inhibitors, as well as vaccines and antibodies The gene may encode 5 commercially important industrial proteins or peptides, such as proteases, carbohydrases such as amylases and glucoamylases, cellulases oxidases and lipases The gene of interest may be a naturally occurring gene, a mutated gene or a synthetic gene The term "homologous protein" refers to a protein or polypeptide native or naturally occurring in a gram-positive host cell The invention includes host cells producing the 0 homologous protein via recombinant DNA technology The present invention encompasses a gram-positive host cell having a deletion or interruption of the nucleic acid encoding the naturally occurring homologous protein, such as a protease, and having nucleic acid encoding the homologous protein, or a variant thereof, re-introduced in a recombinant form In another embodiment, the host cell produces the homologous protein 5 Detailed Description of the Preferred Embodiments The present invention provides novel secretion factors and methods that can be used in gram-positive microorganisms to ameliorate the bottleneck to protein secretion and the production of proteins in secreted form, in particular when the proteins are recombinantly introduced and overexpressed by the host cell The present invention provides the secretion factor SecDF derived from Bacillus subtilis and illustrates that interruption of the nucleic acid encoding SecDF via homologous recombination results in a loss in the host cell's capacity to process and secrete a recombinantly introduced heterologous pro-protein I SecDF Nucleic Acid and Ammo Acid Sequences Nucleic Acid Sequences The secDF polynucleotide having the sequence as shown in Figures 1A-1 E and in Kunst et al , 1997, Nature 390 249-256 (GenBank accession number ID g2635229) encodes the Bacillus subtilis secretion factor SecDF The Bacillus subtilis SecDF was initially identified via a FASTA search of Bacillus subtilis translated genomic sequences The SecD and SecF portions of SecDF of Figures 1A-1 E (see also Figures 13 and 14) were found to have 29 % and 28 % identity to £ coli SecD and SecF respectively Subsequent to Kunst et al , the B subtilis nucleic acid sequence was confirmed and has been submitted to GenBank database with accession number AF024506 The present invention encompasses secDF nucleic acid disclosed in Figures 1A-1 E GenBank accession number ID g2635229 and accession number AF024506 The present invention provides secD polynucleotide secF polynucleotide and secDF polynucleotide which may be used alone or together in a host cell The polynucleotide sequences for SecD and SecF portions of SecDF can be determined from Figures 13 and 14 which show the ammo acid alignment of E coli SecD and SecF with the Bacillus subtilis SecDF In contrast to £ coli secretion factors SecD and SecF and as illustrated in Figure 6, Bacillus subtilis SecDF is encoded by one polynucleotide The SecD operon of E coli consists of the YahC, secD and secF genes (Pog ano et al 1994, J Bacteriol 176 804- 814) This function-related operon structure is not conserved in B subtilis, as the yajC-like gene yrbF and secDF are separated by two pairs of divergently transcribed genes, denoted yrzE, yrbG, spoVB and yrzD The present invention encompasses secD secF and secDF polynucleotide homologs encoding gram-positive secretion factors SecD SecF and SecDF respectively, whether encoded by one or multiple polynucleotides which have at least 80%, or at least 90% or at least 95% identity to B subtilis SecD SecF and SecDF respectively as long as the homolog encodes a protein that is able to function by modulating secretion in a gram-positive microorganism As will be understood by the skilled artisan due to the degeneracy of the genetic code a variety of polynucleotides i e secD, secF and secDF polynucleotide variants, can encode the Bacillus subtilis secretion factors SecD, SecF and SecDF The present invention encompasses all such polynucleotides Gram-positive microorganism polynucleotide homologs of B subtilis secD, secF and secDF secretion factors can be identified through nucleic acid hybridization of gram-positive microorganism nucleic acid of either genomic of cDNA origin The polynucleotide homolog sequence can be detected by DNA-DNA or DNA-RNA hybridization or amplification using probes, portions or fragments disclosed in Figures 1A-1 E Accordingly, the present invention provides a method for the detection of secD, secF and secDF polynucleotide homologs which comprises hybridizing a nucleic acid sample with part or all of a nucleic acid sequence from secD, secF or secDF Also included within the scope of the present invention are secDF, secD and secF polynucleotide sequences that are capable of hybridizing to part or all of the secDF nucleotide sequence of Figures 1A-1 E under conditions of intermediate to maximal stringency Hybridization conditions are based on the melting temperature (Tm) of the nucleic acid binding complex, as taught in Berger and Kimmel (1987, Guide to Molecular Cloning Techniques, Methods in Enzymology, Vol 152, Academic Press, San Diego CA) incorporated herein by reference, and confer a defined ' stringency" as explained below "Maximum stringency" typically occurs at about Tm-5°C (5°C below the Tm of the probe), "high stringency" at about 5°C to 10°C below Tm "intermediate stringency" at about 10°C to 20°C below Tm, and "low stringency" at about 20°C to 25°C below Tm As will be understood by those of skill in the art, a maximum stringency hybridization can be used to identify or detect identical polynucleotide sequences while an intermediate or low stringency hybridization can be used to identify or detect polynucleotide sequence homologs The term "hybridization" as used herein shall include "the process by which a strand of nucleic acid joins with a complementary strand through base pairing" (Coombs J (1994) Dictionary of Biotechnology, Stockton Press, New York NY) The process of amplification as carried out in polymerase chain reaction (PCR) technologies is described in Dieffenbach CW and GS Dveksler (1995 PCR Prjmer 1 _a Laboratory Manual, Cold Spring Harbor Press, Plamview NY) A nucleic acid sequence of at least about 10 nucleotides and as many as about 60 nucleotides from the secDF nucleotide sequence of Figures 1A-1 E, preferably about 12 to 30 nucleotides, and more preferably about 20-25 nucleotides can be used as a probe or PCR primer Ammo Acid Sequences The B subtilis secDF polynucleotide as shown in Figures 1A-1 E encodes B subtilis SecDF The B subtilis secDF gene specifies one protein of 737 residues with a calculated molecular mass of 81 ,653 The SecDF protein has a two-domain structure, consisting of an ammo-terminal SecD domain (about 416 residues) and a carboxyl-terminal SecF domain (291 residues) These domains show significant sequence similarity to known SecD and SecF proteins from other organisms, the highest similarity being found with SecD and SecF proteins from the cyanobacteπum Synechocystis The stretch of 30 residues which links the SecD and SecF domains of B subtilis SecDF is not conserved in other known SecD or SecF proteins The corresponding domains of SecDF also show sequence similarity among themselves, in particular at their carboxyl-termmi (22% identical residues and 44% conservative replacements in a stretch of 200 residues) B subtilis SecDF shows ammo acid sequence similarity to solute transporters, such as AcrF of E coli (42% identical residues and conservative replacements in a stretch of 253 residues) which is involved in acriflavme resistance (GenBank sequence ID number g399429) and Actll-3 of Streptomyces coelicolor (46% identical residues and conservative replacements in a stretch of 159 residues) which is involved in the transport of antibiotics (GenBank sequence ID number g80715) Alignment of B subtilis SecDF with the SecD and SecF proteins from the organisms listed in Table I revealed that these proteins do not show similarity over their entire length Ten short patterns of conserved ammo acids were identified, which are present in all known SecD and SecF proteins As shown in Figure 6C these conserved regions were named D1- D6 and F1-F4 for the SecD and SecF domains/proteins respectively The positions of these conserved regions are indicated in Figure 6C Some of these conserved domains are present in both SecD and SecF This similarity is most obvious for the regions D1 and F1 which, respectively, have the consensus sequence G(L/I)DLRGG and G(L/I)DF(A/T)GG Parts of the conserved regions D5 and F2 also show similarity The present invention encompasses gram positive microorganism ammo acid variants of the ammo acid sequence shown in Figures 1A-1 E that are at least 80% identical, at least 90% identical and at least 95% identical to the sequence shown in Figures 1A-1 E as long as the ammo acid sequence variant is able to function by modulating secretion of proteins in gram-positive microorganisms Table I Percentage of identical residues plus conservative replacements in SecD and SecF domains and proteins from various organisms The GenBank sequence ID numbers are SecD (£ coli) 134399, SecF (£ coli) 134401 , SecD (Huemophilus influenzae) 1173414, SecF (H mfluenzae) 1 173416, SecD (Helicobacter pylori) 2314730, SecF (H pylori) 2314729, SecD (Methanococus jannaschii) 2129225 SecF (M jannaschii) 2129224, SecD (Mycobactenum tuberculosis) 2498898, SecF (AW tuberculosis) 2498900, SecD (Rhodobacter capsulatus) 2252773, SecF (R capsulatus) 22527 '4, SecD (S coelicolor) 1076081 , SecF (S coelicolor) 1076082, SecD (Synechocystis sp ) 1001493, SecF (Synechocystis sp ) 1001494 II Expression Systems The present invention provides expression systems for the enhanced production and secretion of desired heterologous or homologous proteins in gram-positive microorganisms a Coding Sequences In the present invention, the vector comprises at least one copy of nucleic acid encoding a gram-positive microorganism SecD, SecF, or SecDF secretion factor and preferably comprises multiple copies In a preferred embodiment, the gram-positive microorganism is Bacillus In another preferred embodiment the gram-positive microorganism is Bacillus subtilis In a preferred embodiment, polynucleotides which encode β subtilis SecD, SecD and/or SecDF, or fragments thereof, or fusion proteins or polynucleotide homolog sequences that encode ammo acid variants of SecD, SecF and/or SecDF, may be used to generate recombinant DNA molecules that direct the expression of SecD, SecF, SecDF, or ammo acid variants thereof, respectively, in gram-positive host cells In a preferred embodiment the host cell belongs to the genus Bacillus In another preferred embodiment, the host cell is B subtilis As will be understood by those of skill in the art, it may be advantageous to produce polynucleotide sequences possessing non-naturally occurring codons Codons preferred by a particular gram-positive host cell (Murray E et al (1989) Nuc Acids Res 17 477-508) can be selected, for example, to increase the rate of expression or to produce recombinant RNA transcripts having desirable properties, such as a longer half-life, than transcripts produced from naturally occurring sequence Altered gram positive secD, secF or secDF polynucleotide sequences which may be used in accordance with the invention include deletions, insertions or substitutions of different nucleotide residues resulting in a polynucleotide that encodes the same or a functionally equivalent SecD, SecF or SecDF homolog, respectively As used herein a "deletion" is defined as a change in either nucleotide or ammo acid sequence in which one or more nucleotides or ammo acid residues, respectively, are absent As used herein an "insertion" or "addition" is that change in a nucleotide or ammo acid sequence which has resulted in the addition of one or more nucleotides or ammo acid residues, respectively, as compared to the naturally occurring gram positive secD, secF or secDF. As used herein "substitution" results from the replacement of one or more nucleotides or amino acids by different nucleotides or ammo acids, respectively The encoded protein may also show deletions, insertions or substitutions of amino acid residues which produce a silent change and result in a functionally equivalent gram- positive SecD, SecF or SecDF variant Deliberate ammo acid substitutions may be made on the basis of similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the residues as long as the variant retains the ability to modulate secretion For example, negatively charged ammo acids include aspartic acid and glutamic acid, positively charged ammo acids include lysme and argmine, and am o acids with uncharged polar head groups having similar hydrophilicity values include leucine, isoleucme, valme, glycme, alanme, asparagme, glutamme, seπne, threonine, phenylalan e, and tyrosme The secD, secF or secDF polynucleotides of the present invention may be engineered in order to modify the cloning, processing and/or expression of the gene product For example, mutations may be introduced using techniques which are well known in the art, eg, site-directed mutagenesis to insert new restriction sites to alter glycosylation patterns or to change codon preference, for example In one embodiment of the present invention, a secDF, secD or secF polynucleotide may be hgated to a heterologous sequence to encode a fusion protein A fusion protein may also be engineered to contain a cleavage site located between the secDF nucleotide sequence and the heterologous protein sequence so that the SecDF protein may be cleaved and purified away from the heterologous moiety b Vector Sequences Expression vectors used in expressing the secretion factors of the present invention in gram-positive microorganisms comprise at least one promoter associated with a secretion factor selected from the group consisting of SecD, SecF and SecDF, which promoter is functional in the host cell In one embodiment of the present invention, the promoter is the wild-type promoter for the selected secretion factor and in another embodiment of the present invention, the promoter is heterologous to the secretion factor, but still functional in the host cell Additional promoters associated with heterologous nucleic acid encoding desired proteins or polypeptides may be introduced via recombinant DNA techniques In one embodiment of the present invention, the host cell is capable of overexpressing a heterologous protein or polypeptide and nucleic acid encoding one or more secretion factor(s) ιs(are) recombinantly introduced In one preferred embodiment of the present invention, nucleic acid encoding the secretion factor is stably integrated into the microorganism genome In another embodiment, the host cell is engineered to overexpress a secretion factor of the present invention and nucleic acid encoding the heterologous protein or polypeptide is introduced via recombinant DNA techniques The present invention encompasses gram-positive host cells that are capable of overexpressing other secretion factors known to those of skill in the art, including but not limited to, SecA, SecY, SecE or other secretion factors known to those of skill in the art or identified in the future In a preferred embodiment, the expression vector contains a multiple cloning site cassette which preferably comprises at least one restriction endonuclease site unique to the vector, to facilitate ease of nucleic acid manipulation In a preferred embodiment, the vector also comprises one or more selectable markers As used herein, the term selectable marker refers to a gene capable of expression in the gram-positive host which allows for ease of selection of those hosts containing the vector Examples of such selectable markers include but are not limited to antibiotics, such as, erythromycin, actinomycin, chloramphenicol and tetracyclme c Transformation In one embodiment of the present invention nucleic acid encoding one or more gram- positive secretion factor(s) of the present invention is introduced into a gram-positive host cell via an expression vector capable of replicating within the host cell Suitable replicating plasmids for Bacillus are described in Molecular Biological Methods for Bacillus, Ed Harwood and Cutting, John Wiley & Sons, 1990, hereby expressly incorporated by reference, see chapter 3 on plasmids Suitable replicating plasmids for B subtilis are listed on page 92 In another embodiment, nucleic acid encoding one or more gram positive secretion factor(s) of the present invention are stably integrated into the microorganism genome Preferred gram-positive host cells are from the genus Bacillus Another preferred gram- positive host cell is B subtilis Several strategies have been described in the literature for the direct cloning of DNA in Bacillus Plasmid marker rescue transformation involves the uptake of a donor plasmid by competent cells carrying a partially homologous resident plasmid (Contente et al , Plasmid 2 555-571 (1979), Haima et al , Mol Gen Genet 223 185- 191 (1990), Wemrauch et al , J Bacteriol 154(3) 1077-1087 (1983), and Weinrauch et al , J Bacteriol 169(3) 1205-1211 (1987)) The incoming donor plasmid recombmes with the homologous region of the resident ' helper" plasmid in a process that mimics chromosomal transformation Transformation by protoplast transformation is described for B subtilis in Chang and Cohen, (1979) Mol Gen Genet 168 111-115, for B megateπum in Vorobjeva et al , (1980) FEMS Microbiol Letters 7 261-263, for B amyloliquefaciens in Smith et al , (1986) AppI and Env Microbiol 51 634, for B thurmgiensis in Fisher et al , (1981 ) Arch Microbiol 139 213- 217, for B sphaencus in McDonald (1984) J Gen Microbiol 130 203, and B larvae in Bakhiet et al , (1985) 49 577 Mann et al , (1986, Current Microbiol 13 131-135) report on transformation of Bacillus protoplasts and Holubova, (1985) Folia Microbiol 30 97) disclose methods for introducing DNA into protoplasts using DNA containing liposomes III Identification of Transformants Although the presence/absence of marker gene expression suggests that the gene of interest is also present, its presence and expression should be confirmed For example, if the nucleic acid encoding a secretion factor is inserted within a marker gene sequence, recombinant cells containing the insert can be identified by the absence of marker gene function Alternatively, a marker gene can be placed in tandem with nucleic acid encoding the secretion factor under the control of a single promoter Expression of the marker gene in response to induction or selection usually indicates expression of the secretion factor as well Alternatively, host cells which contain the coding sequence for a secretion factor and express the protein may be identified by a variety of procedures known to those of skill in the art These procedures include, but are not limited to DNA-DNA or DNA-RNA hybridization and protein bioassay or immunoassay techniques which include membrane-based, solution- based, or chip-based technologies for the detection and/or quantification of the nucleic acid or protein The presence of the secDF polynucleotide sequence can be detected by DNA-DNA or DNA-RNA hybridization or amplification using probes portions or fragments disclosed in Figures 1A-1 E IV Secretion Assays Means for determining the levels of secretion of a heterologous or homologous protein in a gram-positive host cell and detecting secreted proteins include, using either polyclonal or monoclonal antibodies specific for the protein Examples include enzyme- linked immunosorbent assay (ELISA), radioimmunoassay (RIA) and fluorescent activated cell sorting (FACS) These and other assays are described among other places, in Hampton R et al (1990, Serological Methods, a Laboratory Manual, APS Press, St Paul MN) and Maddox DE et al (1983, J Exp Med 158 1211) A wide variety of labels and conjugation techniques are known by those skilled in the art and can be used in various nucleic and ammo acid assays Means for producing labeled hybridization or PCR probes for detecting specific polynucleotide sequences include ohgolabeling, nick translation end-labeling or PCR amplification using a labeled nucleotide Alternatively, the nucleotide sequence, or any portion of it may be cloned into a vector for the production of an mRNA probe Such vectors are known in the art, are commercially available, and may be used to synthesize RNA probes in vitro by addition of an appropriate RNA polymerase such as T7, T3 or SP6 and labeled nucleotides A number of companies such as Pharmacia Biotech (Piscataway NJ), Promega (Madison Wl), and US Biochemical Corp (Cleveland OH) supply commercial kits and protocols for these procedures Suitable reporter molecules or labels include those radionuclides, enzymes, fluorescent, chemiluminescent, or chromogenic agents as well as substrates, cofactors, inhibitors, magnetic particles and the like Patents teaching the use of such labels include US Patents 3,817,837, 3,850,752, 3,939,350, 3,996,345, 4,277,437, 4,275,149 and 4,366,241 Also, recombinant immunoglobulins may be produced as shown in US Patent No 4,816,567 and incorporated herein by reference V Purification of Proteins Gram positive host cells transformed with polynucleotide sequences encoding heterologous or homologous protein may be cultured under conditions suitable for the expression and recovery of the encoded protein from cell culture The protein produced by a recombinant gram-positive host cell comprising a secretion factor of the present invention will be secreted into the culture media Other recombinant constructions may join the heterologous or homologous polynucleotide sequences to nucleotide sequence encoding a polypeptide domain which will facilitate purification of soluble proteins (Kroll DJ et al (1993) Such purification facilitating domains include but are not limited to metal chelatmg peptides such as histidme-tryptophan modules that allow purification on immobilized metals (Porath J (1992) Protein Expr Punf 3 263-281) protein A domains that allow purification on immobilized immunoglobulin, and the domain utilized in the FLAGS extension/affinity purification system (Immunex Corp Seattle WA) The inclusion of a cleavable linker sequence such as Factor XA or enterokmase (Invitrogen San Diego CA) between the purification domain and the heterologous protein can be used to facilitate purification Example I Example I gives materials and methods for the Examples a Plasmids, bacterial strains and media Table II lists the plasmids and bacterial strains used herein TY medium contained Bacto tryptone (1 %), Bacto yeast extract (0 5%) and NaC1 (1 %) S7 media 1 and 3, for the pulse-labeling of B subtilis were prepared as described in van DIJI et al (1991 , J Gen Microbiol 137 2073-2083) with the exception that glucose was replaced by maltose Minimal medium (GCHE medium, Kunst et al (1995, J Bacteriol 177 2403-2407) contained glucose (1%), potassium L-glutamate (0 2%), potassium phosphate buffer (100 mM, pH 7), trisodium citrate (3 mM), MgSO 4 (3 mM), ferric ammonium citrate (22 rπg/1), casein hydrolysate (0 1%), and L-tryptophan (50 mg/l) Antibiotics were used in the following concentrations chloramphenicol, 5 μg/ml, erythromycm, 1 μg/ml, kanamycm, 10 μg/ml, ampicillin, 50 μg/ml IPTG was used at 1 mM b DNA techniques Procedures for DNA purification, restriction, hgation, agarose gel electrophoresis and transformation of competent £ coli DH5α cells were carried out as described in Sambrook (1989, Molecular cloning a Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA) Enzymes were from Boehnnger (Mannheim, Germany) B subtilis was transformed by adding DNA to cells growing in GCHE medium at the end of the exponential growth phase, and continued incubation for 3-4 hours PCR was carried out with Vent DNA polymerase (New England Biolabs, Beverly, MA), using buffers of the supplier The nucleotide sequences of primers used for PCR (5'-3') are listed below, nucleotides identical to genomic template DNA are printed in capital letters and restriction sites used for cloning are underlined DNA sequences were determined using the didioxy chain- termination procedure (Laemm 1970 Nature, 227 680-685) To verify the previously reported sequence of the B subtilis secF gene (Kunst 1997 supra), a plasmid (pSecDF) was constructed by inserting a DNA fragment containing the entire secDF gene, amplified by PCR with the primers AB34secd (aaaaqcttAAGGGAGGATATACATAATG) and AB37secd (aaqqatccGCGTATGTCATTATAGC . into the HmdlW and Bam l restriction sites of the phagemid pBluescπpt ll+ To construct β subtilis MIF an internal fragment of the secDF gene (417 nucleotides) was amplified by PCR with the oligonucleotides AB32secF (aaaagcttCGACAGAGCAAGTTGAG) and AB33secF (aaggatccGATTGTATCGTTAATGG) and, subsequently, cloned into pMutιn2, which resulted in plasmid pMIF To construct B subtilis MID a fragment containing the ribosome binding site, start codon and the first 879 nucleotides of the secDF gene, but not the secDF promoter(s) was amplified with the primers AB34secD (see above) and AB31 secD (aaqqatccGTGTAATGTAGATATAAAC) and cloned into pMutιn2, resulting in plasmid pMID B subtilis MIF and MID were obtained by Campbell type integration of plasmids pMIF and PMID, respectively, into the chromosome of β subtilis 168 Correct integration of plasmids in the chromosome of β subtilis was verified by Southern hybridization To construct B subtilis XDF-Myc the entire secDF gene was amplified by PCR with the primers AB47secD (aatctaqaAAGGGAGGATATACATAATG) and AB46mycF (aggafccttagttcaaatcttcctcactgatcaatttctgTTCTTGCGCCGAATCTTTTTTCAG), the sequence specifying the human c-Myc epitope is indicated in bold) The resulting PCR product, which contains the secDFmyc gene, was cleaved with Xoal and Bam l, and hgated into the Spel and βamHI sites of pX This resulted in plasmid pXDFmyc, which contains the secDFmyc gene under the transcriptional control of the xylose-mducible xy/A promoter Upon transformation of B subtilis 168 with pXDFmyc, both the xylA promoter and secDFmyc were integrated into the chromosomal amyE gene, resulting in B subtilis XDF-Myc The disruption of the amyE gene was confirmed by growing β subtilis XDF-Myc on TY plates containing 1 % starch and subsequent exposure of the plates to iodine As shown by a lack of halo formation, β subtilis XDF-Myc did not secrete active α-amylase c Pulse-chase protein labeling, immunoprecipitation, SDS-PAGE and fluorography- Pulse-chase labeling experiments with B subtilis and immunoprecipitations were performed as described in van Dijl et al , 1991 , J Gen Microbiol 137 2073-2083 SDS-PAGE was performed according to Laemmli (1970, Nature 227 680-685) [ 14 C]-methylated molecular weight markers were from Amersham (Little Chalfont UK) Fluorography was performed with Autofluor (National Diagnostics, Atlanta Georgia USA) Relative amounts of precursor and mature forms of secreted proteins were estimated by scanning of autoradiographs with an LKB ultrascan XL laser densitometer (LKB, Bro ma Sweden) d Western blot analysis- Western blotting was performed using a semi-dry system as described in Miller supra After separation by SDS-PAGE proteins were transferred to Immobilon-PVDF membranes (Millipore Corp Bedford MA) Proteins were visualized with specific antibodies and horseradish peroxidase (HRP) anti-rabbit or anti-mouse IgG conjugates, using the ECL detection system of Amersham Streptavidm-IIRP conjugate was obtained from Amersham e Protease accessibility- Protoplasts were prepared from exponentially growing cells of β subtilis To this purpose cells were concentrated 5-fold in protoplast buffer (20 mM potassium phosphate, pH 7 5, 15 mM MgC1 2 , 20% sucrose) and incubated for 30 mm in the presence of 1 mg/ml lysozyme (37°C) Next, the protoplasts were collected by centnfugation and resuspended in fresh protoplast buffer The protease accessibility of membrane proteins was tested by incubating the protoplasts at 37°C in the presence of 1 mg/ml trypsin (Sigma Chemical Co , St Louis, MO, USA) for various periods of time The reaction was terminated by the addition of 1 2 mg/ml trypsin inhibitor (Sigma Chemical Co ) Finally, protoplasts were collected by centnfugation, and the degradation of specific proteins was analyzed by SDS- PAGE and Western-blotting In parallel, protoplasts were incubated without trypsin, or in the presence of trypsin and 1 % Triton X-100 Samples containing TX-100 were directly used for SDS-PAGE after the addition of trypsin inhibitor f β-Galactosidase activity- Overnight cultures were diluted 100-fold in fresh medium and samples were taken at hourly intervals for optical density (OD) readings at 600 nm and β-Galactosidase activity determinations The β-Galactosidase assay and the calculation of β-Galactosidase units (per OD600) were performed as described in Miller, 1982, Experiments in Molecular Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA Table II Plasmids and Bacterial Strains Strain/Plasmid Genotype/Properties Source/Reference Strains DH5 F80dlacZ-M15 endAI recAI hsdR17(r k m „.) thι-1 gyrA96 Bethesda Research relAI-(lacZYA-argF) U169 Laboratories β subtilis 168 trpC2 Kunst et al (supra) MIF trpC2, secDF pMIF, Em' Examples MID trpC2, secDF pMID, Em r Examples XDF-Myc trpC2, amyE xylA-secDFmycCrri Examples Plasmids pBluescπpt II KS+ cloning vector, Ap r Stratagene pSecDF pBluescπpt II KS+ derivative carries the β subtilis Examples secDF gene pX vector for the integration of genes in the amyE locus of Kim et al 1996, β subtilis, integrated genes will be transcribed from Gene 181 71-76 the xylA promoter, carries the xylR gene, Ap r , Cm r pXDFmyc pX derivative, carries the β subtilis secDFmyc gene Examples downstream of the xylA promoter pMutin2 pBR322-based integration vector for B subtilis, V Vagner and S.D contains a multiple cloning site downstream of the Ehrlich Pspac promoter (Yansura et al , 1984, Genetics and Biochemistry of Bacilli pp 249-263 Academic Press, Orlando, USA), and a promoterless lacZ gene preceded by the πbosome-binding site of the spoVG gene, Ap r , Em r pMIF pMutιn2 derivative, carries an internal fragment of the Examples secDF gene pMID pmutιn2 derivative, carries the 5' part of the B subtilis Examples secDF gene pKTHI O Contains the amyQ gene of β amyloliquefaciens, Km r Palva, 1982, Gene 19 81-87 pKTH10-BT pKTHI O derivative, encodes the AmyQ-PSBT fusion Tjalsma et al 1998 protein Example II This Example describes the membrane topology of Bacillus subtilis SecDF Algorithms described by Sipos and von Heijne (Sipos et al ,1993, Eur J Biochem 213 1333- 1340) predict that the SecDF (Bsu) protein has twelve membrane-spanning domains, the amino- and carboxyl-termmi being localized in the cytoplasm Two large extracellular loops are localized between the first and second, and the seventh and eighth membrane-spanning domains, respectively (Fig 15) These predictions are in good agreement with the topology models proposed for SecD and SecF of £ coli, in which both SecD and SecF have six membrane-spanning domains with large periplasmic loops being located between the first and second membrane-spanning domains (Pogliano, 1994 supra) To verify the predicted cytoplasmic localization of the carboxyl-terminus of SecDF, we studied the protease-accessibility of SecDF-Myc in protoplasts As shown by Western blotting, two trypsm-resistant SecDF-Myc-denved fragments of about 54 kDa and 23 kDa were detectable upon incubation of intact protoplasts of xylose-induced β subtilis XDF-Myc cells with trypsin Under the same conditions, the B subtilis signal peptidase SipS, of which a large part is exposed to the external side of the membrane (van Dijl et al, EMBO J 11 2819-2828), was completely degraded by trypsin whereas the cytoplasmic protein GroEL remained unaffected In contrast, both SecDF-Myc-denved fragments and GroEL were completely degraded by trypsin when protoplasts were lysed by the addition of 1 % Triton X- 100 Taken together, these findings show that the carboxyl-terminus of SecDF-Myc is protected against trypsin in intact protoplasts, suggesting that the carboxyl-terminus of B subtilis SecDF is localized in the cytoplasm To study the kinetics of the formation of the two trypsm-resistant SecDF-Myc-denved fragments, limited proteolysis experiments were performed in which protoplasts of xylose- induced B subtilis XDF-Myc cells were incubated with trypsin for various periods of time As shown by Western blotting, the 54 kDa fragment is a transiently existing intermediate product in the degradation of intact SecDF-Myc to the trypsm-resistant 23 kDa fragment As judged from the apparent molecular masses of the trypsm-resistant fragments, it is most likely that trypsin cleavage of SecDF-Myc occurs in the two predicted extracellular domains between the first and second membrane-spanning domains, and the seventh and eighth membrane- spanning domains Example III This Example relates to the cold-sensitive growth of B subtilis secDF mutants To analyze the effects of SecDF depletion on cell growth and protein secretion, two mutant β subtilis strains were constructed with the mtegrative plasmid pMutιn2 (provided by V Vagner and S D Ehrlich, INRA, Jouy en Josas, France) In the first strain, denoted B subtilis MID, the encoding sequence of the secDF gene was left intact but the secDF promoter was replaced with the IPTG-mducible Pspac promoter, present on pMutιn2, in the second strain, denoted β subtilis MIF, the coding sequence of the SecDF gene was disrupted with pMutin 2 (Fig 16A and 16B, respectively) The point of truncation of the SecDF protein of B subtilis MIF is indicated in Fig 6C Irrespective of the growth medium used or the presence of IPTG, both β subtilis MID and MIF showed growth rates at 37°C similar to that of the parental strain β subtilis 168, demonstrating that under these conditions SecDF was not essential for growth and viability of the cells By contrast, SecDF was important for growth in TY medium at 15°C compared to the growth of the parental strain (Fig 16C, indicated by the closed square), the growth of β subtilis MID (in the absence of IPTG) and β subtilis MIF was significantly reduced In fact the growth rates of the two latter strains were reduced to the same extent (Fig 16C, indicated by the closed triangle and circle respectively) and, in addition, the cells of both strains showed a filamentous morphology Growth of B subtilis MID AT 15°C could be restored by the addition of IPTG to the growth medium (Fig 16C, indicated with the closed tnange), though not completely to wild-type levels Similarly, growth of β subtilis MIF at 15°C could be restored to a similar level as that of B subtilis MID in the presence of IPTG, by introducing the secDF-myc gene in the amyE locus, indicating the c- Myc tag did not interfere with SecDF function Interestingly the growth defects of β subtilis MID (in the absence of IPTG) and MIF were not observed instantaneously upon incubation at 15°C, as both strains showed growth rates comparable to those of the parental strain until the mid-exponential growth phase (OD600=0 3-0 4 Fig 16C) To test whether SecDF might be even more important for growth under conditions of hyper-secretion, the β subtilis MID and MIF strains were transformed with plasmid pKTHIO, which results in the secretion of the Bacillus amyloliquefaciens α-amylase AmyQ at high levels (*1 3 g/l, Kontmen et al , 1988, J Gen Microbiol, 134 2333-2344 and Palva, 1982, Gene 19 81-87) Irrespective of the presence of pKTHI O growth of B subtilis MID and MIF at 37°C was not affected In contrast at 15 °C B subtilis MID (in the absence of IPTG) and MIF cells transformed with pKTHIO completely stopped growing after reaching the mid- exponential growth phase and, subsequently, cells even started to lyse (Fig 16C, indicated with the open triangle and circle, respectively) The latter observation showed that the cold- sensitive phenotype of cells depleted of SecDF was exacerbated by high levels of AmyQ secretion The presence of pKTHI O did not affect the growth at 15°C of either the parental strain, or B subtilis MID in the presence of IPTG (Fig 16C, indicated with the open triangle), showing that high-level secretion of AmyQ per se did not affect the growth of B subtilis at low temperature Taken together, these observations show that the B subtilis SecDF (Bsu) protein is required for efficient growth at low temperatures, in particular under conditions of high-level protein secretion Example IV This Example demonstrates that SecDF is required for efficient secretion of AmyQ To investigate the importance of SecDF for protein secretion at moderate levels (about 30 mg of protein per liter), the secretion of the neutral protease NprE by B subtilis MIF was analyzed by Western blotting Both at 37°C and 15°C, the absence of SecDF did not result in the accumulation of pre-NprE, and similar amounts of mature NprE were detected in the medium of B subtilis MIF and the parental strain To evaluate the importance of SecDF under conditions of hyper-secretion, the secretion of AmyQ into the growth medium was investigated by Western blotting experiments The results showed that B subtilis MIF (pKTHI O) secreted reduced levels of AmyQ into the culture medium This was most clearly observed with cells in the transition phase between exponential and post-exponential growth which had been washed and resuspended in fresh medium If the washed cells were incubated for 1 hour at 37°C, the medium of B subtilis MIF contained about 65% ± 10%of the amount of AmyQ secreted by the parental strain An even more drastic effect was observed at 15°C after 16 hours of incubation, the medium of β subtilis MIF contained about 40% ± 10% of the amount of AmyQ secreted by the parental strain The reduced secretion of AmyQ into the medium by β subtilis MIF was paralleled by an increased accumulation of pre-AmyQ in the cells Since the cellular levels of mature AmyQ were not affected in the absence of intact SecDF, these data suggest that SecDF is required for the efficient translocation of pre-AmyQ, but not the release of mature AmyQ from the membrane To investigate the important of SecDF for the translocation of pre-AmyQ, β subtilis MIF was transformed with plasmid pKTH10-BT 2 , which specifies a hybrid AmyQ protein containing the biotm-acceptmg domain (PSBT) of a transcarboxylase from Propionibactenum shermannn (Jander et al , 1996, J Bacteriol 178 3049-3058) fused to its carboxyl-terminus The rationale of this experiment is that pre-AmyQ-PBST will only be biotmylated by the cytoplasmic biotin-ligase if the rate of translocation of pre-AmyQ-PSBT is slowed down to such an extent that the PSBT-domam can fold into its native three-dimensional structure and accept biotin before transport across the membrane To investigate the importance of SecDF for the translocation of pre-AmyQ, B subtilis MIF was transformed with plasmid pKTH10-BT 2 , which specifies a hybrid AmyQ protein containing the biotin-accepting domain (PSBT) of a transcarboxylase from Propionibactenum shermannn (Jander, supra) fused to its carboxyl-terminus The rationale of this experiment is that pre-AmyQ-PSBT will only be biotmylated by the cytoplasmic biotin-ligase if the rate of translocation of pre-AmyQ-PSBT is slowed down to such an extent the PSBT-domam can fold into its native three-dimensional structure and accept biotin before transport across the membrane Cells lacking intact SecDF accumulate biotmylated pre-AmyQ-BT, whereas no biotmylated (pre-)AmyQ-PSBT was detected in cells of the parental strain of β subtilis XDF- Myc, which were transformed with pKTH10-BT These finds show that the rate of translocation of pre-AmyQ-PSBT is significantly reduced in cells lacking SecDF To determine the rate of pre-AmyQ translocation in the absence of SecDF, the kinetics of pre-AmyQ processing by signal peptidase were studied by pulse-chase labeling of β subtilis MIF containing pKTHIO Even at 37°C the rate of pre-AmyQ processing was decreased in cells lacking an intact SecDF gene after a chase of 1 mm about 32% of the labeled AmyQ was mature in B subtilis MIF whereas under the same conditions, about 59% of the AmyQ was mature in the parental strain The effects of the absence of intact SecDF were even more pronounced at 23°C after a chase of 4 mm mature AmyQ was hardly detectable in B subtilis MIF whereas under the same conditions about 40% of the labeled AmyQ was mature in the parental strain Pulse-chase labeling experiments were also performed with B subtilis XDF-Myc, which overproduces the SecDF-Myc protein upon induction with xylose Overproduction of SecDF-Myc did not significantly influence the rate of pre-AmyQ processing showing that wild-type levels of SecDF are not limiting for the translocation of pre-AmyQ and that overproduction of SecDF-myc does not interfere with normal SecDF function Example V This example describes the growth phase and medium-dependent transcription of the secDF gene To test whether the transcription of the secDF gene depends on the growth phase or medium composition as previously shown for the signal peptidase-encodmg genes sipS and s/pT (Bolhuis et al 1996, Mol Microbiol 22 605-618 and Tjalsma, 1997, J Biol Chem , 272 25983-25992) we made use of the transcriptional secDF-lacZ gene fusions present in B subtilis MID and MIF B subtilis MIF was grown in three different media (minimal medium, TY, or TY supplemented with 1 % glucose) and samples withdrawn at hourly intervals were assayed for β-galactosidase activity Nearly constant levels of β- galactosidase activity were observed during growth in minimal medium suggesting that the secDF gene was expressed constitutively In contrast cells grown in TY medium showed increasing levels of β-galactosidase activity during exponential growth, with a maximum at the beginning of the stationary phase The β-galactosidase activity decreased in the post- exponential growth phase suggesting that secDF promoter activity was highest in the transition phase between the exponential and post-exponential growth phase The addition of 1 % glucose to TY medium caused a drastic increase in the β-galactosidase levels of cells in the post-exponential growth phase, showing that glucose strongly stimulates the transcription of the secDF gene Taken together, these findings show that the transcription levels of the secDF gene depend on the growth phase and growth medium Example VI This Example illustrates that secDF encodes one protein To show that the secDF gene encodes only one protein of approximately 82 kDa the 3' end of the secDF gene was extended with 11 codons, specifying the human c-Myc epitope (EQKLISEEDLN Evan et al , 1985, Mol Cell Biol 5 3610-3616) Next, the myc-tagged secDF gene (secDF-myc) was placed under the transcriptional control of the xylose-mducible xylA promoter and, subsequently, integrated via a double-crossover replacement recombination into the amyE locus of β subtilis, using the pX system developed by Kim et al (1996, Gene 181 71-76) The resulting strain was named B subtilis XDF-Myc As shown by Western blotting and subsequent immuno-detection with c-/Wyc-specιfιc monoclonal antibodies, the SecDF-Myc protein was produced in β subtilis XDF-Myc cells growing in TY medium supplemented with 1 % xylose, but not in cells growing in TY medium lacking xylose Similar results were obtained if samples for Western blotting were prepared from intact cells or protoplasts of B subtilis XDF-Myc Immunodetection with SecDF-specific antibodies showed that the SecDF- Myc protein was highly overproduced in xylose-induced cells of β subtilis XDF-Myc, as neither wild-type SecDF nor SecDF-Myc were detectable in unmduced cells Judged from its mobility on SDS-PAGE, SecDF-Myc is a protein of about 82 kDa, which is in agreement with the sequence-based prediction Example VII Detection of gram-positive microorganisms The following example describes the detection of gram-positive microorganism SecDF DNA derived from a gram-positive microorganism is prepared according to the methods disclosed in Current Protocols in Molecular Biology, Chap 2 or 3 The nucleic acid is subjected to hybridization and/or PCR amplification with a probe or primer derived from SecDF A preferred probe comprises the nucleic acid section containing conserved ammo acid sequences The nucleic acid probe is labeled by combining 50 pmol of the nucleic acid and 250 mCi of [gamma ^ ] adenosme tnphosphate (Amersham, Chicago IL) and T4 polynucleotide kmase (DuPont NEN®, Boston MA) The labeled probe is purified with Sephadex G-25 super fine resin column (Pharmacia) A portion containing 10 7 counts per minute of each is used in a typical membrane based hybridization analysis of nucleic acid sample of either genomic or cDNA origin The DNA sample which has been subjected to restriction endonuclease digestion is fractionated on a 0 7 percent agarose gel and transferred to nylon membranes (Nytran Plus, Schleicher & Schuell, Durham NH) Hybridization is carried out for 16 hours at 40 degrees C To remove nonspecific signals, blots are sequentially washed at room temperature under increasingly stringent conditions up to 0 1 x saline sodium citrate and 0 5% sodium dodecyl sulfate The blots are exposed to film for several hours the film developed and hybridization patterns are compared visually to detect polynucleotide homologs of β subtilis SecDF The homologs are subjected to confirmatory nucleic acid sequencing Methods for nucleic acid sequencing are well known in the art Conventional enzymatic methods employ DNA polymerase Klenow fragment SEQUENASE® (US Biochemical Corp Cleveland, OH) or Taq polymerase to extend DNA chains from an o gonucleotide primer annealed to the DNA template of interest Various other examples and modifications of the foregoing description and examples will be apparent to a person skilled in the art after reading the disclosure without departing from the spirit and scope of the invention, and it is intended that all such examples or modifications be included within the scope of the appended claims All publications and patents referenced herein are hereby incorporated in their entirety

Claims: CLAIMS 1 An expression vector comprising nucleic acid encoding at least one gram- positive microorganism secretion factor selected from the group consisting of SecD, SecF and SecDF, wherein said secretion factor is under the control of expression signals capable of overexpressing said secretion factor in a gram-positive organism 2. The expression vector of Claim 1 wherein said gram-positive organism is a Bacillus. 3 The expression vector of Claim 1 wherein the Bacillus is selected from the group consisting of B subtilis, B licheniformis, B lentus, B brevis, B stearothermophilus, B alkalophilus, B amyloliquefaciens, B coagulans, B circulans, B lautus and Bacillus thurmgiensis 4 A gram positive microorganism comprising the expression vector of Claim 1 5 The microorganism of Claim 4 that is a Bacillus 6 The microorganism of Claim 5 wherein the Bacillus is selected from the group consisting of B subtilis, B licheniformis, B lentus B brevis, B stearothermophilus, B alkalophilus, B amyloliquefaciens, B coagulans, B circulans B lautus and Bacillus thurmgiensis 7 The microorganism of Claim 4 wherein said host cell is capable of expressing a heterologous protein 8 The microorganism of Claim 7 wherein said heterologous protein is selected from the group consisting of hormone, enzyme, growth factor and cytokme 9 The microorganism of Claim 8 wherein said heterologous protein is an enzyme 10 The microorganism of Claim 9 wherein said enzyme is selected from the group consisting of a proteases, cellulases, amylases, carbohydrases, and lipases, isomerases such as racemases, epimerases, tautomerases, or mutases, transferases, kinases and phophatases 11. An improved method for secreting a protein in a gram-positive microorganism comprising the steps of obtaining a gram positive microorganism comprising nucleic acid encoding at least one Bacillus secretion factor selected from the group consisting of SecD, SecF and SecDF wherein said secretion factor is under the control of expression signals capable of expressing said secretion factor in a gram-positive microorganism said microorganism further comprising nucleic acid encoding said protein; and culturing said microorganism under conditions suitable for expression of said secretion factor and secretion of said protein. 12. The method of Claim 11 wherein said protein is homologous to said host cell. 13. The method of Claim 1 wherein said protein is heterologous to said host cell. 14. The method of Claim 1 1 wherein said gram-positive organism is a Bacillus. 15. The method of Claim 14 wherein said Bacillus is selected from the group consisting of B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B. circulans, B. lautus and Bacillus thuringiensis. 16. The method of Claim 13 wherein said heterologous protein is selected from the group consisting of a hormones enzymes growth factor and cytokine. 17. The method of Claim 16 wherein said heterologous protein is an enzyme. 18. The method of Claim 17 wherein said enzyme is selected from the group consisting of a proteases, cellulases, amylases, carbohydrases, reductases and lipases, isomerases, transferases, kinases and phophatases.

Inventors: QUAX WILHELMUS J, QUAX, WILHELMUS, J.
Applicants: GENENCOR INT, GENENCOR INT BV, QUAX WILHELMUS J, GENENCOR INTERNATIONAL B.V., GENENCOR INTERNATIONAL, INC., QUAX, WILHELMUS, J.
Application year: 1998
Main classification: C12N15
IPC codes: C07K14, C12N1, C12N15, C12P21, C12R1